Literature DB >> 12611566

Factors affecting esophageal motility in gastroesophageal reflux disease.

Emmanuel Chrysos1, George Prokopakis, Elias Athanasakis, George Pechlivanides, John Tsiaoussis, Apostolos Mantides, Evaghelos Xynos.   

Abstract

BACKGROUND: There are conflicting data concerning the effect of gastroesophageal reflux disease (GERD) on esophageal motor function. HYPOTHESIS: Duration of GERD might affect severity of symptoms, grade of esophageal mucosal injury, and esophageal motor behavior.
DESIGN: Retrospective study of a defined cohort. SETTINGS: Two referral centers, one of them academic, for esophageal gastrointestinal motility disorders. PATIENTS: One hundred forty-seven patients with documented GERD. MAIN OUTCOME MEASURES: Symptoms, grade of mucosal injury on esophagoscopy, esophageal manometry, ambulatory esophageal pH monitoring, and esophagogram.
RESULTS: Patients with GERD had significantly decreased lower esophageal sphincter resting pressure (P =.02), lower amplitude of esophageal peristalsis at all levels of measurement (P<.001), and more delayed esophageal transit (P =.007) compared with control subjects. Patients with dysphagia, severe esophagitis, and Barrett esophagus presented with a longer history of the disease, significantly worse esophageal motor function (P<.01), and more prolonged esophageal transit than patients without the above features of the disease. Impairment of esophageal peristalsis and lower esophageal sphincter resting pressure were significantly inversely related to the duration of the disease (P<.001). Also, delay of esophageal transit was significantly related to the duration of the disease (P =.002) and inversely related to the amplitude of esophageal peristalsis (P<.001). Unlike the manometric variables, the extent of reflux, as assessed by ambulatory 24-hour esophageal pH monitoring, was not related to the duration of the disease.
CONCLUSION: A long history of GERD is more commonly associated with presence of dysphagia, delayed esophageal transit, severe esophagitis, presence of Barrett esophagus, and impaired esophageal motility.

Entities:  

Mesh:

Year:  2003        PMID: 12611566     DOI: 10.1001/archsurg.138.3.241

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  8 in total

1.  Esophagitis impairs esophageal smooth muscle reactivity in the rat model: an in vitro study.

Authors:  Melih Tugay; Firuzan Yildiz; Tijen Utkan; Bahar Müezzinoğlu; Faruk Erden; Nejat Gacar; Güner Ulak
Journal:  Dig Dis Sci       Date:  2003-11       Impact factor: 3.199

2.  Is there an association between hiatal hernia and ineffective esophageal motility in patients with gastroesophageal reflux disease?

Authors:  Leonardo Menegaz Conrado; Richard Ricachenevsky Gurski; André Ricardo Pereira da Rosa; Aleksandar Petar Simic; Sídia Maria Callegari-Jacques
Journal:  J Gastrointest Surg       Date:  2011-08-10       Impact factor: 3.452

Review 3.  Gastrointestinal complications of fundoplication.

Authors:  Frances Connor
Journal:  Curr Gastroenterol Rep       Date:  2005-06

4.  Effects of manometrically discovered nonspecific motility disorders of the esophagus on the outcomes of antireflux surgery.

Authors:  Vic Velanovich; Arvind Mahatme
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

5.  Laparoscopic repair of type III/IV giant para-oesophageal herniae with biological prosthesis: a single centre experience.

Authors:  A K Shrestha; M Joshi; L DeBono; K Naeem; S Basu
Journal:  Hernia       Date:  2019-01-19       Impact factor: 4.739

6.  Esophageal mucosal damage may promote dysmotility and worsen esophageal acid exposure.

Authors:  Adam T Meneghetti; Pietro Tedesco; Tanuja Damani; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.267

7.  Electrical lower esophageal sphincter augmentation in patients with GERD and severe ineffective esophageal motility-a safety and efficacy study.

Authors:  Matthias Paireder; Ivan Kristo; Reza Asari; Gerd Jomrich; Johanns Steindl; Erwin Rieder; Sebastian F Schoppmann
Journal:  Surg Endosc       Date:  2019-01-22       Impact factor: 4.584

Review 8.  NF-κB: A novel therapeutic pathway for gastroesophageal reflux disease?

Authors:  Mao-Lin Zhang; Long-Qing Ran; Meng-Jun Wu; Qin-Chen Jia; Zhi-Ming Qin; Yong G Peng
Journal:  World J Clin Cases       Date:  2022-08-26       Impact factor: 1.534

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.